Aurinia Pharmaceuticals $AUPH has been consolidating throughout 2018, but broke above this consolidation by the end of the year into early 2019. AUPH Daily Chart (click to enlarge)What to Make of this Breakout:- We can see that by the turn of the year, there was a strong bull run that broke above a falling resistance from 2017 as well as the sideways resistance from of 2018. - For pharmaceuticals, I am usually skeptical of breakouts. I would definitely not chase, but I would consider buying on a dip. - Also, I would anticipate sharp pullbacks. This means, instead of looking at the $6.75 pivot or even $6.40 pivot as possible support, I would wait for a deeper pullback towards the $5.50 pivot and December-low. This was also the starting point of the bullish swing that broke above key resistance levels.- Note that the cluster of moving averages is around $6.00. A pullback to this area is therefore not bearish, but could be just a regression back to the mean during a bullish run.